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and consistent in vivo application of liquid 
nitrogen cryogenic spray
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Abstract: In this article, a novel cryotherapy approach using a uniform, controlled, and 
consistent in vivo application of liquid nitrogen (LN
2
) spray as a Metered Cryospray™ (MCS) 
process is described. Although MCS may be used for many potential clinical applications, this 
paper focuses on the development that led to the controlled and consistent delivery of radial 
LN
2
 cryogen spray in order to generate a uniform circumferential effect and how the amount 
of MCS can be adapted to specifically ablate targeted diseases within a patient’s lumen such as 
an airway or esophagus.
Keywords: Metered Cryospray™, cryoablation, rejuvenative healing, LN
2
 spray cryotherapy
Introduction
For several decades, cryogenic freezing and regenerative healing have been used by 
dermatologists.1–4 Since the first medical use of liquid nitrogen (LN
2
) on external body 
surfaces, a significant number of peer-reviewed medical articles on its cryothermic 
use have been published.5 These applications often incorporate the spraying of LN
2
 
or other cryogen on a skin feature, for example, a mole, to ablate the feature with a 
subsequent regenerative or rejuvenative healing process with little or no scarring.
More recently, cryogenic ablation of lesions and diseases has transitioned to within 
the body (eg, Liapi and Geschwind6). Common approaches include the use of a cryo-
probe7 or needle8,9 that is placed into direct contact with the targeted tissue. These 
cryoprobes commonly use a compressed gas, such as argon, nitrous oxide, or carbon 
dioxide, which is allowed to rapidly expand into an enclosed volume, typically the tip 
of the cryosurgical unit. By the Joule–Thomson (J-T) effect,10 the temperature of the 
compressed gas drops significantly and freezes the adjacent tissue; −40°C to −89°C 
have been routinely achieved with these devices, whereas some LN
2
-based cryoneedles 
achieve −160°C. The J-T process enables such cryogens to ablate various tissues rang-
ing from benign to malignant and drives slow freezing of the targeted tissue over a 
period of several to 10s of minutes. Initial cooling from normal body temperature to 
0°C slows the cellular metabolism.11 As the cooling continues from 0°C to −20°C, ice 
crystals begin to form in the extracellular environment. As a result, free intracellular 
water is osmotically pulled from the cells and into the partially frozen extracellular 
medium, resulting in cellular dehydration and shrinkage. This may also cause cellular 
death due to dehydration effects (Figure 1).
Unlike other cryogen devices that hold the cryogen within a contained probe or a 
needle, CSA Medical Inc. has pioneered the use of an LN
2
 spray within the body to 
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enable ablation of lesions (ie, benign, preinvasive, and malig-
nant) and strictures within the gastrointestinal tract12,13 and 
upper airways14–16 by placing a cryocatheter into the working 
channel of an endoscope. The Company’s proprietary, com-
mercially available medical device, the truFreeze System® 
(CSA Medical, Lexington, MA, USA), employs a computer-
driven method and apparatus to transport LN
2
 from a Dewar 
inside the control console through a catheter and into a patient 
allowing LN
2
 to be sprayed directly on the targeted tissue.17 
The sprayed LN
2
, at a temperature of −196°C, impacts tissue 
and produces a flash freezing of the lesion with the forma-
tion of intracellular ice crystals  (Figure 1) before cellular 
dehydration can occur.18 These ice crystals further aggregate 
during the recovery (thawing) phase disrupting intracellular 
organelles such as mitochondria and endoplasmic reticulum 
while leaving the cell wall intact. The disruption of these 
energy-producing organelles leads to cell death. The ablated 
dead cells lose their cellular attachments or become apoptotic 
and are either reabsorbed, disintegrate, or “sluff-off ” of the 
membrane wall, thus exiting the body. Following LN
2
 spray 
procedures, healing follows in a rejuvenative fashion with 
minimal or no scarring.
In stark contrast are the heat ablation modalities such as 
radiofrequency, Bovie cautery, laser, and argon plasma coagu-
lation. These ablation applications cause thermal fixation of 
tissue, a process of cellular and protein denaturation, lead-
ing to cell wall breakdown causing exposure of intracellular 
proteins to the immune system and leading to a reparative 
healing, the hallmark of which is fibrotic scarring.19
As is typical of an ablative cryosurgical tool, the truFreeze 
System allows the physician to determine the rate and total 
duration of cryogen delivery. The physician decides on the 
length of time that the cryogen be applied based on the char-
acteristics of the abnormal tissue to be addressed.
CSA Medical Inc. is continuing to advance the applica-
tion of the rejuvenative effects of LN
2
 within various medical 
applications such as the use of a radial spray within lumens 
such as the airways or esophagus. In order to effectively 
ablate and potentially treat specific benign or malignant 
diseases or tissues, a predetermined and consistent amount 
of circumferential LN
2
 cryogen spray must be delivered to 
the targeted areas within the patient’s airway or esophagus 
that provides cryogenic ablation and healing effects in a safe 
and efficacious manner. This LN
2
 spray approach is branded 
“Metered Cryospray™” (MCS). The following sections of 
this article describe the overall considerations of the MCS 
approach, test methods and results, and specific anatomical 
considerations of MCS. 
MCS technical considerations
Development approach 
The development phase of MCS was structured around the 
establishment of test fixtures and methods to evaluate the 
MCS cooling performance. This process followed a four-step 
methodology (Figure 2). First, numerical modeling was used 
to approximate the effect of MCS on human tissue and tissue 
mimetic gels including ballistic gels and high-temperature 
nontoxic (HTNT) gels. HTNT gel is a hydrogel consisting 
of water, sorbitol, starch, disodium phosphate, and iota car-
rageenan, which has been designed to melt at a temperature 
significantly above 37°C required to simulate human body 
temperature. The model was developed by using properties 
obtained from literature,20,21 as well as differential scanning 
calorimetry (DSC) and thermal conductivity measurement 
of mucosal tissue and the gel mimetics in both frozen and 
unfrozen states. Then, gels were used to visually determine 
the appropriate radial head configuration that would produce 
a uniform spray with a circumferential effect over a range of 
Figure 1 Cooling-induced cellular changes. 
Fast cooling
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lumen diameters. This spray distribution was evaluated by 
using phase Doppler particle analyzer (PDPA) and a LaVision 
laser sheet imager. Then, a more focused effort to establish 
the material properties of the gels and test fixture hardware 
and methods was made for quick system evaluations. These 
gel-based test fixtures revealed the need for further control 
of the cryogen delivery, including bench simulation of an 
in vivo bronchoscope using a heated water jacket in order 
to simulate more closely the anticipated treatment condi-
tions. Data from these bench tests led to the incorporation 
of a catheter-mounted thermocouple and development of a 
temperature-driven control algorithm. Additional testing and 
modeling was necessary to establish a correlation between 
the gels and in vivo use of MCS. A porcine luminal model 
(bronchial airway lumen) was the chosen in vivo model, 
given the ability to access these lumens with a conventional 
bronchoscope. 
Significant accomplishments were establishing cryospray 
parameters in gel studies and then confirming the tissue 
effects with pathology results from animal studies. A key pro-
cess to establish the correlation of test stand measurements 
of gel with animal pathology was the use of viability stain-
ing19,22 that would identify the cryoablated intact dead cells in 
a recently-treated extirpated animal tissue. Correlation was 
then facilitated by using a transient numerical heat transfer 
model (two-phase, with melting/solidification) exhibiting 
measured temperature-dependent gel thermal properties (ie, 
conductivity, density, and specific heat), gel fixture geometry, 
and measured thermal properties of porcine mucosal tissue. 
Given the thermal mapping data obtained during sprays in 
gel, the surface heat transfer properties are inferred for the 
proxy and then applied to a numerical model incorporating 
the geometry and properties of the porcine tissue. Model 
validation was accepted when the results of the porcine model 
matched the known injury depth (associated with the −20°C 
isotherm) for a given spray duration and intensity. 
When the correlation between gel and bronchial tissue 
was established, the length of injury, depth of injury (DOI), 
and uniformity of radial pattern leading to circumferential 
LN
2
 distribution were evaluated. As noted, the overall goal 
was to demonstrate that MCS achieved a consistent, uni-
formly radial LN
2
 spray in lumens of varying diameters and 
lengths, resulting in DOIs within depth ranges anticipated 
by in vitro gel models. A series of HTNT gel tests were 
performed for several lumen sizes that are found to occur in 
animal and human airways: 6, 8, 12, and 18 mm. The purpose 
of this study was to evaluate centered LN
2
 sprays and the 
resulting overall DOI in order to confirm temperature regimes 
for various acute animal studies. The catheter thermocouple 
temperatures were adjusted until the resulting DOI fits within 
the boundaries of a 0.1–0.5 mm DOI based on the established 
correlation between HTNT gel and porcine bronchial tissue 
(demonstrated with viability staining).
Numerical modeling
In order to understand the relevance of temperatures gener-
ated in HTNT gel test fixtures in predicting the amount of 
LN
2
 that would be necessary to ablate human tissue to a 
specific depth, the thermal characteristics of our porcine 
model bronchial-wall human tissue proxy and our HTNT gel 
model had to be determined. After obtaining porcine bron-
chial tissue from a recently slaughtered pig from a local meat 
packing house (Blood Farm, West Groton, MA, USA), the 
bronchial epithelium was dissected from the cartilage wall. 
This tissue specimen along with a representative sample of 
HTNT gel was sent for analysis to Analytical Answers, Inc. 
(Woburn, MA, USA), who studied the thermal properties of 
both samples by using DSC per ASTM E1269.
Then, a two-dimensional axisymmetric thermal fluid 
model in COMSOL,23 a finite element analysis software 
package, was developed. From this work, two models were 
created, one for human bronchial tissue using the data gath-
ered by testing the thermal properties of porcine bronchial 
tissue (Table 1) and the second for HTNT gel (Table 2). A 
convective heat flow model was used as the surface bound-
ary condition at the lumen interior. The tissue was modeled 
by using Penne’s equation and includes latent heat associ-
ated with phase change and crystallization as well as the 
metabolic rate and the perfusion rate. The gel was modeled 
as a solid with temperature-dependent properties and phase 
change. MCS was then delivered to the surface of HTNT gel 
embedded with thermocouples at specific depths (ie, 0.25, 
Figure 2 Gels and test fixture process.
Abbreviation: MCS, Metered Cryospray™.
Numerical
model
Predict effects of
MCS on tissue
Confirm effects of
MCS correlate to
predictive model
Confirm effects of
MCS correlate to
mimetic model
Confirm effects of
MCS correlate to
ex vivo model
Tissue
mimicking
model
Ex vivo In vivo
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0.70, and 2.0 mm) in a 3 mm thick wall. The temperatures 
obtained from these thermocouples embedded in HTNT gel 
were interpreted by using the models to predict the depth of 
thermal penetration that would occur in bronchial wall tissue.
Establishing radial head geometry
It is desirable to use a single radial pattern in order to 
uniformly generate an outwardly directed radial LN
2 
spray 
onto the walls of lumens of varying diameters. However, for 
lumens with large diameter and length such as those found in 
the esophagus or trachea, a multirow design was determined 
to be more effective in producing uniform and consistent LN
2
 
sprays. An evaluation of a variety (Figure 3) of catheter hole 
patterns in the tip was conducted to characterize spray out-
puts. The test matrix included two LN
2
 sprays each in lumen 
phantoms of three inner diameters constructed of ballistic 
gel to visualize freeze zones (including radial uniformity 
and depth and length of freeze zone); measurements of flow 
rates and power delivered over a series of three LN
2
 sprays 
using specific test fixtures; and measurements of the rate of 
temperature change of the lumens, evenness of spray, and 
the final temperature achieved.
Figure 4 shows the results of one of the set of tests per-
formed in an 18 mm lumen (used as a reference point for one 
of the largest airway lumen diameters that would be medically 
relevant) for one of the hole pattern configurations. This 
sample generated a uniform circumferential freeze zone in 
the various quadrants in all relevant lumen diameters. Other 
samples did not achieve the same uniform spray results.
For measurements of spray evenness around lumen cir-
cumference, the rate of temperature change, and the final 
temperature achieved, lumens were configured with between 
four and 240 ultrafine thermocouples (0.0025 cm diameter) in 
selected locations (Figure 5). Each lumen was sprayed using 
the same 25s spray time, repeated three times for confirmation 
of repeatability. This length of time was chosen as it allowed 
for detectable thermal penetration into the gel, no matter the 
lumen diameter. Figure 6 shows a typical testing result. One 
notes that a high degree of consistency was observed in the 
thermal profile for each of the thermocouple units.
Upon completion of the testing, a finite element analysis 
of the most favorable designs was conducted to determine the 
most robust solution. Figure 7 shows a typical mesh pattern 
Table 1 Thermal property data for porcine tracheal mucosa 
(Analytical Answers, Inc., Woburn, MA, USA)
Property Value Units Tolerance
Melt/solidification temperature 3.5 °C ±1.5
Latent heat of fusion 207 J/g ±4
Crystallization temperature −14 °C ±1
Latent heat of crystallization −96 J/g ±10
Specific heat capacity at 20°C 3.85 J/g-K ±0.2
Specific heat capacity at −20°C 1.92 J/g-K ±0.06
Thermal conductivity at 20°C 0.453 W/m-K ±0.05
Thermal conductivity at −170°C 1.619 W/m-K ±0.85
Density 1050 kg/m3 ±10
Table 2 Thermal property data for high-temperature nontoxic 
(HTNT) gel (Analytical Answers, Inc., Woburn, MA, USA)
Property Value Units Tolerance
Melt/solidification temperature −1.82 °C ±0.1
Latent heat of fusion 142 J/g ±9
Crystallization temperature −18.5 °C ±0.3
Latent heat of crystallization 141 J/g ±4
Specific heat capacity at 20°C 6.76 J/g-K ±0.03
Specific heat capacity at −20°C 4.05 J/g-K ±0.01
Thermal conductivity at 25°C 0.624 W/m-K ±0.06
Thermal conductivity at −170°C 1.083 W/m-K ±0.03
Figure 3 Hole patterns tested for spray capabilities.
Figure 4 Freeze zone determinations in ballistic gel for LN2 spray testing.
Figure 5 Test structure with multiple thermocouples (black arrow) embedded 
in gel.
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and simulation of stresses. Given that this catheter enters the 
body via the working channel of an endoscope, consideration 
of the maximal scope insertion force applied at the distal 
face was used to simulate the greatest axial compression. 
Determination of the von Mises stress and maximal displace-
ments were completed, and the most robust of the various 
patterns was selected.
Spray characterization testing
In order to more fully understand the LN
2
 spray conditions, 
additional characterization tests were performed. In particu-
lar, a PDPA and a LaVision laser sheet imager were employed 
to provide more detailed data on the spray characteristics. 
These tests were performed at Spray Analysis and Research 
Services (Spraying Systems Co., Wheaton, IL, USA) and 
encompassed both open end spray and radial spray catheters.
A PDPA (TSI Inc., Shoreview, MN, USA) provides data 
on spray drop sizes and velocity distributions by taking point 
measurements at multiple locations within a spray plume. 
With the test apparatus, the laser point size is a few microns in 
diameter, and the point must traverse across the edges of the 
spray plume to capture data on the plume size edge-to-edge, 
drop sizes at each position about the plume, and velocity at 
each of the points evaluated. Figure 8 shows an image taken 
during testing with a radial spray catheter.
Two distances, selected to closely match the existing 
human lumen diameters of 7.8 and 9.8 mm, were used in order 
to capture the full extent of the spray profile. The edges of 
the spray were determined by examining a decrease in both 
drop velocity and the number of drops observed. Typically, at 
the edge of the spray, the data rate is reduced from >10,000 
drops in a 30s period to ~500 drops over the same time period.
The PDPA examined D
V0.1
, D
V0.5
, D
V0.9
, and D
32
 diameters 
where these parameters are a means of expressing drop size 
in terms of the volume of LN
2
 sprayed (Table 3). D
V0.1
 is the 
value where 10% of the total volume (or mass) of LN
2
 sprayed 
is made up of drops with diameters smaller than or equal to 
this value; D
V0.5
 is the median volume diameter where 50% 
of the total volume of LN
2
 sprayed is made up of drops with 
diameters larger than the median value and 50% smaller than 
the median value; and D
V0.9
 is where 90% of the volume of 
LN
2
 sprayed is made up of drops with diameters smaller than 
or equal to this value. D
32
 is the Sauter mean diameter and 
is a means of expressing the fineness of a spray in terms of 
the surface area produced by the spray. It is the diameter of 
a drop having the same volume-to-surface area ratio as the 
total volume of all the drops to the total surface area of all 
of the drops.
There is a significant reduction in velocity and overall 
drop size between the straight spray catheter and the radial 
spray catheters. This is due to the effects of shear in the 
catheter as the LN
2
 abruptly changes direction right before 
exit. These measurements demonstrated that the radial spray 
catheter provides a more diffused and controlled spray, and 
thus, it is expected to be able to more effectively spray more 
delicate areas of the body with lumens of smaller diameter.
Figure 9 shows the average drop diameter (D
V0.5
) for 
the end spray catheter at various points across the spray 
plume for two different test runs. The shape and overlay 
of the runs demonstrate excellent repeatability. It is also 
Figure 6 Temperatures as a function of spray time for 18 mm lumen diameter 
(T Ch refers to each embedded thermocouple).
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Figure 7 Mesh and stress simulation for test radial pattern.
Figure 8 Phase Doppler particle analyzer measurement of catheter spray output.
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interesting to note that the general shape of this graph, with 
smaller drops occurring near the center and larger drops 
occurring near the edges, is the opposite of what would 
be expected from a full-cone, narrow-angle hydraulic 
nozzle spraying water. Water would exhibit larger drops 
in the center of the nozzle and smaller drops at the edges. 
However, this graph is consistent with a multiphase flow in 
which the core is high-speed gas and the annulus is slow-
moving/wetted liquid. The small droplets at the center are 
fine mist particles as an artifact of the flow regime. The 
large annulus of droplets is caused by the natural breakup 
of the exiting liquid content near the walls. This charac-
teristic of spray may be ideal for LN
2
 cryospray ablation 
as it distributes the freezing power more evenly across the 
spray as in an annulus.
Laser sheet imaging (LSI) was conducted by using a 
LaVision SprayMaster system to obtain qualitative and quan-
titative visualization of the LN
2
 spray process. This integrated 
imaging system uses a laser sheet to simultaneously measure 
the intensity of the individual spray plumes radiating from 
each of the radial head openings. Laser light sheets slice 
through the plume with high temporal and spatial resolution. 
The approach helps to determine the spray concentration 
distribution and focuses on the size, shape, and relative 
distribution of the spray plume to provide two-dimensional 
(planar cross section) spray concentration results. Figure 10 
shows one of the sets of images obtained from a radial spray 
catheter that was oriented to spray vertically downward so the 
laser sheets describe a plane that cuts through an axial posi-
tion centered on one of the two rows of holes in the catheter 
tip. As may be noted, the image shows a very radially sym-
metric LN
2
 spray (in both patterning and intensity) with a 
clear differentiation between the centers of the spray plumes 
from the forward and rear offset catheter holes.
These combined (PDPA and LSI) tests provided useful 
data on the characteristics of the LN
2
 sprays for various cath-
eter configurations to guide selection of the optimum variant 
for the radial spray catheter to be used in further preclinical 
Table 3 Phase Doppler particle analyzer results of drop size for various catheter types
Catheter type Liquid pressure (psi) Spray height (mm) DV0.1 (µm) D32 (µm) DV0.5 (µm) DV0.9 (µm) Average velocity 
(m/sec)
Straight orifice open end 19 8 48 79 91 155 115
44 65 85 148 115
Offset radial orifice 19 4 32 55 65 121 25
33 57 67 124 23
In−line radial orifice 19 3 34 60 73 136 23
Figure 9 Open-end catheter droplet size (DV0.5) across spray plume. 
Notes: Blue (square data points)/green (diamonds) are Spray 1; red (circles)/yellow (triangles) are Spray 2.
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and clinical studies. In particular, these tests demonstrate that 
the radial design generates consistent, even, and overlapping 
annular plumes that result in a smooth circumferential effect 
in cylindrical lumens.
Core probe and cavity pressure test 
fixtures
A measurement system that is repeatable and reproducible 
for the purpose of evaluating LN
2
 cryospray output was 
required for design verification testing. This type of mea-
surement system made it possible to evaluate part-to-part 
variation of components with the confidence necessary to 
ensure data consistency and stability. A core probe fixture 
and a cavity pressure fixture were designed to measure the 
total cryogen delivery performance (defined as total cool-
ing energy output of the system as controlled by using the 
MCS time and temperature conditions) and the resulting 
pressure built during a cryospray from LN
2
 to N
2
 conversion, 
respectively. Figure 11 shows a schematic diagram of the 
core probe and a photograph of a nominal test setup. The 
core probe includes a cylindrical body of known mass and 
heat transfer properties with a thermocouple that is thermally 
bonded to the mass to measure total energy transmitted to 
the probe during an LN
2
 spray. The catheter (typically used 
in the working channel of an endoscope) is mounted within 
a heated water jacket (37°C) to simulate LN
2
 spraying in a 
body cavity.
Figure 12 shows a schematic representation of the cavity 
pressure test fixture. This device consists of a known volume 
with metering valve and pressure transducer to determine the 
cavity pressure during controlled LN
2
 spray that subsequently 
transitions into N
2
 gas. This method allowed an evaluation 
of the N
2
 gas pressure generated with LN
2
 sprays to use as a 
proxy of pressure to assess the most stressful conditions that 
may arise during in vivo human use. These tests confirmed 
that the maximum cavity pressure remained below 40 cm 
H
2
O for metered cryosprays of <25 s and demonstrated 
that, for pressure considerations, MCS may be used safely 
in esophageal or airway lumens in humans.24
Porcine animal model testing
Throughout the development of MCS, the results noted in 
HTNT gel studies were measured against findings from in 
vivo testing in the porcine animal model. In order to deter-
mine the depth to which the cryothermic ablation effect 
penetrated the bronchial airway wall, viability staining was 
applied on bronchial tissue extirpated after treatment. Viabil-
ity staining is based on the principle that regions of thermal 
tissue necrosis may be identified by using a reaction that 
converts a colorless salt to a colored formazan pigment within 
viable tissues. There are two compounds used for this process: 
1) triphenyltetrazolium chloride (TTC), and 2) nitro blue 
tetrazolium (NBT). Both these compounds use the dehydro-
genase enzyme cofactor reaction to enact a full color change 
with viable tissues (colorless to red maroon with TTC and 
colorless to blue-black with NBT) or a partial color change 
in mixed viability tissues (colorless to pink with TTC and 
colorless to grey with NBT). Nonviable or necrotic tissues 
that lack intact enzymatic activity to metabolize the salts do 
not stain. TTC staining is optimally used macroscopically to 
detect thermal necrosis and its boundary with viable tissues. 
NBT staining is optimally used to microscopically detect 
thermal necrosis and its boundary with viable tissues.19,22 
Figure 13 shows a comparison of normal and cryospray-
treated tissues visualized with NBT staining.
A series of short-term survival (<1 h after the completion 
of MCS treatment in vivo to euthanasia and tissue extirpa-
tion) porcine animal studies were evaluated at the completion 
of the design phase using final MCS control parameters. 
Terminal temperatures governed the amount of spray used 
in relationship with the diameter of the measured airways 
(Figure 14) and led to adequate depths of tissue ablation 
providing in vivo confirmation of the data generated from 
test fixtures.
Moreover, animal testing also identified a potential 
variable (mucus or other fluids within the working channel 
Figure 10 Radial catheter laser sheet imaging showing droplet counts as a function 
of position (inset image in lower right corner shows enlarged center pattern image. 
Inset scale not shown).
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Figure 12 Schematic of cavity test fixture for a 6 mm lumen diameter.
Metering value
Pressure
transducer
6 mm volume
Figure 11 Core probe measurement system to determine LN2 cryospray output.
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water jacket holder
of the endoscope is a source of change in flow enthalpy 
during a cryospray) that could affect the MCS control 
algorithm by delaying the time to reach the minimum target 
 temperature (as measured by the thermocouple on the cath-
eter). With the inclusion of a maximum time limit coupled 
with empirically selected bounding conditions (slope and 
R2 value of a linear curve fit of the catheter thermocouple 
temperature data), metered cryosprays with excessive 
amounts of material in the bronchoscope working channel 
are automatically detected and terminated, prompting user 
intervention. A scope cleaning technique was demonstrated 
to be an effective means of removing excessive amounts 
of material from the endoscope, facilitating subsequent 
successful sprays.
Despite some variation in pathological findings due 
to the sectioning method, many LN
2
 cryosprayed sections 
revealed circumferential to nearly circumferential effect to 
the optimal target depth range of 0.1–0.5 mm in porcine 
airways by using the final empirically developed MCS 
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Figure 13 NBT stain identifies cryothermic effects by staining nontreated cells 
(dark blue), whereas treated cells remain unstained.
Note: Stain changes color based on viable cell energy production.19,22
Abbreviation: NBT, nitro blue tetrazolium.
Epithelium
Submucosa
Smooth muscle
Cartilage ring
NBT staining –
Untreated bronchus
NBT staining – treated bronchus
showing cryotherapy transition zone
treatment protocol. In total, five confirmatory acute animal 
studies were performed confirming the tissue depth of treat-
ment (Figure 15).
Catheter temperature correlation
A series of tests were completed to determine the cor-
relation of the catheter temperature with catheter energy 
output as this would allow for a repeatable and controlled 
 application of LN
2
 spray. The thermocouple that was affixed 
to the catheter at the distal end was used to measure the 
catheter temperature as a function of spray time and lumen 
size. These measurements demonstrated that there was a 
strong, direct relationship between the terminal tempera-
ture (ie, the net energy removal from the stainless catheter 
wall) and the amount of LN
2
 delivered to targeted ablation 
areas. Figure 14 shows the relationship of lumen diameter 
with catheter terminal temperature. The selected terminal 
temperatures and the cooling rate of change as measured by 
the catheter thermocouple caused a desired effect in porcine 
bronchial tissue as a result of cooling delivery performance 
(energy output).
When the control algorithm was established, the length 
of injury, DOI, and uniformity of radial pattern distribution 
were evaluated. As noted, the overall goal was to demon-
strate that MCS achieved a consistent, uniform, radial LN
2
 
spray in lumens of varying diameters and lengths, resulting 
in DOIs circumferentially within anticipated ranges (for 
development purposes, a target DOI range of 0.1–0.5 mm 
was used; however, the control system can be adjusted to 
achieve any DOI determined to be clinically required, within 
the limits of the cryogen delivery). A series of HTNT gel 
tests were performed for several lumen sizes: 6, 8, 12, and 
18 mm. The purpose of this study was to evaluate centered 
LN
2
 sprays and the resulting overall DOI in order to confirm 
terminal catheter temperature settings for various acute 
animal studies. The catheter thermocouple termination tem-
peratures were adjusted until the resulting DOI fits within 
the boundaries of 0.1–0.5 mm  based on the established 
correlation between HTNT gel and porcine bronchial tissue 
(demonstrated with viability staining). Figure 16 displays 
the resulting minimum HTNT gel temperature at 0.25 mm 
as a function of spray duration. The polynomial curve fits in 
Figure 16 correspond to lethal isotherms (−20°C) in tissue 
at the indicated depths, as determined by using correlated 
numerical modeling.
By using ballistic gel, a complementary series of tests 
with varying lumen sizes was completed to determine the 
length of the injury resulting from an LN
2
 MCS. Table 4 
shows the results.
A further series of HTNT gel tests were performed to 
evaluate the overall length of injury at various nominal 
depths for centered sprays in relation to other variables. The 
following conditions were evaluated:
1. Off-center catheter: half the distance from center to 
luminal wall (expected variation in clinical use);
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Figure 15 Representative porcine model distal trachea.
Note: Purple line (open arrow) depicts essentially circumferential MCS treatment 
effect.
Abbreviation: MCS, Metered Cryospray™.
Cartilage
Bronchial epithelium,
no treatment effect Bronchial epithelium,
treatment effect
2. Off-center catheter: 1 mm from the luminal wall (worst-
case scenario);
3. 2X overdose of LN
2
 spray (misuse and/or exaggerated 
anatomical variation);
4. Temperature for low-energy limit;
5. Maximum time cutoff;
6. Two sprays with 1 cm pull-back in an 8 mm lumen.
The lengths and DOIs were measured for each of these 
clinically relevant challenge conditions. Figure 17 shows a 
representative result for an 8 mm lumen diameter. 
Spray effects were evaluated by using perfect and nonper-
fect use conditions with the catheter centered in the lumen 
and conditions that simulate the anticipated variation of 
clinical use such as the catheter off-center in the lumen and 
variation in lumen diameter (Figure 18). As observed, with 
off-center catheter positioning, the temperature distribution 
profile still produces a circumferential DOI within desired 
parameters.
The gel testing and animal testing were an iterative 
process that established the relationships between the two 
methods. The outcome yielded the MCS parameters required 
to inform an algorithm that would deliver a controlled and 
uniform amount of LN
2
 at desired depths in tissue. MCS 
automatically delivers an appropriate amount of LN
2
 spray 
as a function of lumen diameter, based on a maximum 
spray time or a threshold catheter temperature, whichever 
comes first.
Summary
This article summarizes the development of a novel cryo-
spray system that delivers a controlled, disease- or tissue-
specific, and repetitively consistent radial spray of LN
2
 
through a catheter delivered into the human body through 
the working channel of an endoscope. Unlike cryoprobes 
or external topical LN
2
 spray used for general tissue abla-
tion, this system could be used to apply LN
2
 cryospray 
for specific disease conditions as well as for ablation of 
unwanted tissue. The basis of the process is the regenerative 
or rejuvenative healing that results from flash-freeze LN
2
 
cryogenic ablation.
Figure 14 Catheter terminal temperature versus lumen size.
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In order to address specific disease conditions, the LN
2
 
cryospray process requires novel controls to ensure that 
the amount delivered is indeed consistent. The ability to 
 correlate the temperature trace of a thermocouple located 
on the distal end of the spray catheter to the intended cryo-
thermic tissue treatment was the key to achieve cryospray 
control, a process that has been identified as MCS. This 
development required first comparing and modeling the 
thermal characteristics of targeted human tissue to gel-based 
test fixtures. Such a process allowed for interpretation of 
data generated from subsequent gel-based test fixtures 
and core probes. This correlation was carried through the 
development process.
Safe egress of the nitrogen gas generated during the state 
transition of LN
2
 from the internal organ system being sprayed 
with LN
2
 is essential. Modeling the gas pressure developed 
within an organ during spray cryotherapy and its evacuation is 
essential for a safe LN
2
 application process. Through specific 
test fixtures and analysis of gas egress patterns, safe LN
2
 cryo-
spray methods have been determined such that the nitrogen gas 
generated during MCS egresses safely from the target organ.
The depth of cryoablation in a specific organ to produce the 
desired effect on the abnormal epithelial lining will be defined 
by the disease process. The gel and core-probe test fixtures 
enable predictions of the amount of MCS and to subsequently 
document the in vivo tissue effect using a porcine animal model. 
This tissue model requires the use of a special tissue staining 
process that identifies cell layers that have been ablated due 
to the inability of cryo-treated cells to generate energy. These 
viability stains change from clear to specific color within cells 
that are still viable and energy-producing, whereas the intact 
nonviable cells do not stain. Such animal studies are the final 
proxy for the anticipated in vivo human effect from MCS.
The test proxies noted in this report support the 
thoughtful and methodical development of safe use of this 
approach.
Table 4 Ballistic gel length of injury measurements
Lumen diameter 
(mm)
Approximate length of injury 
(mm)
6 4–6
8 5–7
10 7
12 7–8
18 9–12
Figure 16 Correlation of HTNT gel temperatures with DOI. 
Notes: The DOI is determined by looking at the contour lines. For example, the “1” data point (a 14s spray with a gel temperature of 3oC) falls between the 0.1 and 0.25 
mm DOI lines; therefore, in a human, it would be expected to see a DOI between 0.1 and 0.25 mm. The “2” data point is a DOI between 0.25 and 0.5 mm. The “3” data 
point falls between 0.5 and 0.75 mm, and the “4” data point is on the line at 0.5 mm.
Abbreviations: DOI, depth of injury; HTNT, high-temperature nontoxic; Poly., polynomial fit.
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Figure 18 Centered spray (left) and off-center spray (right) final temperature profiles in HTNT gel with a 12 mm lumen.
Notes: Actual catheter position is denoted with a bold X. Small x markers indicate locations of embedded thermocouples on rings of 0.25, 0.75, and 3 mm depth relative 
to the lumen surface. Color scales are in °C.
Abbreviation: HTNT, high-temperature nontoxic.
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Figure 17 Length of injury measurements of MCS in an 8 mm diameter of HTNT gel.
Abbreviations: HTNT, high-temperature nontoxic; MCS, Metered Cryospray™.
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